1 results match your criteria: "Department of Hematology Oncology of Karamay Central Hospital[Affiliation]"
Effects of hsa-miR-28-5p on Adriamycin Sensitivity in Diffuse Large B-Cell Lymphoma.
Evid Based Complement Alternat Med
July 2022
Department of Hematology Oncology of Karamay Central Hospital, Number 67, Junggar Road, Karamay Region, Karamay 834000, The Xinjiang Uygur Autonomous Region of China, China.
Background: Adriamycin (doxorubicin) is an important traditional drug that exhibits cytotoxicity in Diffuse Large B-cell Lymphoma (DLBCL). Doxorubicin affects the DLBCL cells at all stages of their cell cycle. Combined with our previous results, this study discovered that the overexpression of hsa-miR-28-5p inhibited the proliferation, promoted apoptosis, and triggered cell cycle arrest at the S-phase in DLBCL cells.
View Article and Find Full Text PDF